AN2 Therapeutics (ANTX), a clinical biotech, jumped into the first trading day of spring 2022 by launching its IPO early Monday morning (March 21) for pricing on Thursday night. Shares of AN2 Therapeutics popped on Friday (March 25), opening at $16.85 – up 12.3 percent from their IPO price at $15 – on their first […]
March 21, 2022 Read MoreAkanda Corp. (AKAN proposed), a small medical cannabis company, soared in its NASDAQ debut on Tuesday (March 15, 2022) – opening at $30 – or 7.5 times its $4 IPO price. The Akanda deal was the first traditional IPO of March 2022 – braving the market’s chilly waters at a time when Wall Street was […]
March 14, 2022 Read MoreFour SPACs – and no IPOs – got done in the first week of March. The world watched in horror after Russian military forces attacked a nuclear plant in southeastern Ukraine on Thursday night (March 3, 2022). The attack provoked fear of a meltdown “that could dwarf the world’s worst nuclear disaster, at Ukraine’s Chernobyl […]
March 5, 2022 Read MoreMarch is off to a subdued start with only 1 SPAC – Valuence Merger Corp. I (VMCAU) – making its trading debut today as all eyes are on Russia’s escalation of attacks on Ukraine. U.S. stocks opened lower and extended their decline by midday, following their drop on Monday (Feb. 28), the first trading day after […]
March 1, 2022 Read MoreClean Earth Acquisitions Corp. (CLINU) priced its SPAC IPO on Wednesday night (Feb. 23, 2022) – just ahead of breaking news that Russia had attacked Ukraine. Clean Earth’s stock and warrants are expected to start trading today (Thursday, Feb. 24) on the NASDAQ. The Wall Street Journal reports that the NASDAQ Composite Index is edging […]
February 24, 2022 Read MoreBankers may be starting the Valentine’s Weekend early after navigating a rocky stock market this week and pricing 16 deals – mostly SPACs plus a sprinkling of small-cap IPOs and uplistings – to raise about $1.24 billion. The week’s mix included a public offering after an uplisting. (This column, initially published on Monday, Feb. 7, […]
February 7, 2022 Read MoreArcellx (ACLX), a cancer-focused biotech, shot up to $19 at its opening trade on Friday (Feb. 4, 2022) – up $4 from its IPO price – in its NASDAQ debut. Arcellx priced its IPO on Thursday (Feb. 3, 2022) at $15 – the low end of its $15-to-$17 range – on 8.25 million shares. The […]
January 31, 2022 Read MoreCredo Technology Group Holding, Ltd. (CRDO) slashed the number of shares in its IPO and priced the deal at $10 – the low end of its $10-to-$12 range – on Wednesday night (Jan. 26, 2022). The deal was cut to 20 million shares, down from 25 million in the prospectus, to raise $200 million – […]
January 27, 2022 Read MoreCredo Technology Group Holding Ltd. (CRDO proposed), a semiconductor connectivity solutions provider, is the name to note as January 2022 enters its final week. Credo is the only large deal on this week’s IPO Calendar – in a market frozen by fear of rising interest rates ahead and inflation at a 40-year high. The NASDAQ […]
January 23, 2022 Read MorePostponed is the word of the day. Bitcoin miner Rhodium Enterprises, Inc. (RHDM proposed) and a REIT, Four Springs Capital Trust (FSPR proposed), have pulled their IPOs – both expected to start trading today (Thursday, Jan. 20, 2022) – “due to market conditions.” The NASDAQ’s slide into correction territory on Wednesday was the reason. “They […]
January 20, 2022 Read More